ARTEMIs Consortium Meeting 2024

BC Platforms, a proud founding member of ARTEMIs, is excited to attend the 2024 Consortium Meeting in Barcelona with its fellow participants.

ARTEMIs is a 4-year project launched on January 2024, to advance the management of MAFLD, Europe’s leading cause of chronic liver disease (CLD). ARTEMIs aims to control this fast-growing metabolic syndrome and its complications by leveraging advanced liver and heart Virtual Twins. The project will co-design, develop, and evaluate a clinical decision support system (CDSS) for managing MAFLD patients.

ARTEMIs is funded by the European Union under the Horizon Europe program, grant agreement N° 101136299.

Learn more about the consortium: https://www.bcplatforms.com/eu-consortia